RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 183.4 USD | -0.20% |
|
+3.27% | +6.63% |
| 05:21am | ResMed Declares Quarterly Dividend as Fiscal Q3 Profit Jumps 29%; Shares Up 7% | MT |
| 12:12am | ResMed tops quarterly profit estimates on strong demand for sleep apnea devices | RE |
Presenter SpeechLyanne Harrison (Analysts)Mick, thank you so much for coming to our conference...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
183.4
USD
Average target price
206.1
USD
Spread / Average Target
+12.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.63% | 26.94B | |
| +7.71% | 218B | |
| +6.25% | 182B | |
| +10.60% | 132B | |
| +26.73% | 108B | |
| -0.57% | 62.51B | |
| +15.42% | 52.98B | |
| -1.89% | 47.59B | |
| -1.91% | 39.96B | |
| +11.16% | 39.22B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Transcript : ResMed Inc. Presents at BofA Securities Global Healthcare Conference 2022, Sep-14-2022 08
